Table 5 |
||||||
|
WOMAC stiffness scores by group and visit |
||||||
|
Group |
||||||
|
UP446 250 mg/day |
UP446 500 mg/day |
Celecoxib 200 mg/day |
Placebo |
|||
|
|
||||||
|
Visit |
Baseline |
Mean |
3.53 |
3.47 |
2.90 |
2.87 |
|
Std Deviation |
1.08 |
0.95 |
0.87 |
0.85 |
||
|
30 Days |
Mean |
2.67 |
2.77 |
2.58 |
3.37 |
|
|
Std Deviation |
0.65 |
0.84 |
0.73 |
0.83 |
||
|
60 Days |
Mean |
2.50 |
2.58 |
2.50 |
2.85 |
|
|
Std Deviation |
0.76 |
0.79 |
1.19 |
0.99 |
||
|
90 Days |
Mean |
2.57 |
2.15 |
2.17 |
2.96 |
|
|
Std Deviation |
0.83 |
0.85 |
1.01 |
0.72 |
||
|
|
||||||
|
Sampalis and Brownell Nutrition Journal 2012 11:21 doi:10.1186/1475-2891-11-21 |
||||||
